Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.
Leslie Bennett, MSN, RN
Advertisement
Articles by Leslie Bennett, MSN, RN
Nurses should be educated on cranial nerve impairment that may affect those with multiple myeloma who receive cilta-cel, says Leslie Bennett, MSN, RN.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer
2
ASCO Updates 340B Policy Statement to Expand Access, Improve Transparency
3
Cevostamab May Fill Gap in Multiple Myeloma Armamentarium
4
Learning to Implement Novel Cellular Therapies in Hematologic Oncology Care
5